CANCER RESEARCH TRAINING IN NUCLEAR MEDICINE

该培训计划的目标是为医生和基础科学家的职业生涯做好准备，重点是在癌症的诊断和治疗中开发和使用放射性核苷酸。要求支助五名受训人员，他们可能是医生或基础科学家。医师培训生将完成核医学委员会认证要求的主要部分。基础科学培训生需持有化学、物理、生物或相关学科的博士学位。每个人的目标都是在学术环境中从事研究工作。培训计划将持续两到三年。基础广泛的教学课程将全面涵盖核医学应用于癌症的领域。每个受训者将在高级教师导师的协调下专注于选定的课程。具体研究方向有：(1)肿瘤抗体/放射性药物；(2)内分泌肿瘤；(3)脑肿瘤；(4)放射性药物治疗；(5)放射性核素定量成像；(6)放射性药物开发。其中一个或多个方向的研究至少需要学员50-75%的时间。该项目将在核医学部和综合癌症中心进行。培训将由大型多学科核医学学院的成员监督。该小组每年发表90多篇论文，每年获得600多万美元的研究经费支持。核医学设施包括90,000平方英尺的诊所空间，17,000平方英尺的实验室空间，专用回旋加速器和3台PET扫描仪。该项目与密歇根大学综合癌症中心的活动相结合。教师的积极性、结构化的课程、优良的设施和一流的智力环境相结合，有望使个人成为未来癌症研究领域的领导者。

The goal of this training program is to prepare physicians and basic scientists for careers focused on the development and use of radionucleotides in the diagnosis and treatment of cancer. Support is requested for five trainees, who may be either physicians or basic scientists. Physician trainees will have completed the major portion of requirements for board certification in nuclear medicine. Basic science trainees will hold the Ph.D. degree in chemistry, physics, biology, or a related science.. Each will be aiming for a career in research in a academic setting. The training program will be two to three years in duration. A broad based didactic curriculum will cover fully the field of nuclear medicine as applied to cancer. Each trainee will give focused concentration in selected tracks coordinated by a senior faculty mentor. Specific research tracks are: (1) Tumor antibodies/radiopharmaceutical, (2) Endocrine tumors, (3) Brain tumors, (4) Radiopharmaceutical therapy, (5) Quantitative radionuclide imaging, and (6) Radiopharmaceutical development. Research in one or a combination of these tracks will involve at least 50-75% of trainee time. The program will be conducted in the Division of Nuclear Medicine and Comprehensive Cancer Center facilities. Training will be supervised by members of the large, multi- disciplinary nuclear medicine faculty. This group publishes over 90 papers per year and receives over 6 million dollars per year in research grant support. Nuclear Medicine facilities include 90,000 square feet of clinic space, 17,000 square feet of laboratory space, a dedicated cyclotron, and 3 PET scanners. This program is integrated with University of Michigan Comprehensive Cancer Center activities. The combination of faculty motivation, structured curricula, excellent facilities, and superb intellectual environment is expected to prepare individuals to be tomorrow's leaders in cancer research.